Vuno signs deal with Latin American PACS firm
Medical artificial intelligence company Vuno recently signed a memorandum o...Read more on AuntMinnie.comRelated Reading: Vuno signs R&D deal with Mayo Clinic for precision oncology Can AI help screen for early interstitial lung disease on x-rays? Evidence may be lacking for automated MRI analysis in dementia Vuno, Samsung expand AI collaboration Vuno inks deal with Samsung integrating AI with mobile x-ray (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 13, 2022 Category: Radiology Source Type: news

‘Phage therapy’ successes boost fight against drug-resistant infections
Two US patients recover from intractable infections, giving hope for treatments beyond antibioticsTwo US patients have recovered from intractable infections after being treated with a pioneering therapy involving genetically engineered bacteria-killing viruses.The cases raise hopes that so-called phage therapy could be used more widely to combat the global crisis of drug-resistant infections. One of the patients, Jarrod Johnson, a 26-year-old man with cystic fibrosis, was approaching death after suffering a chronic lung infection that resisted treatment by antibiotics for six years. After being given the phage therapy, his...
Source: Guardian Unlimited Science - May 13, 2022 Category: Science Authors: Hannah Devlin Science correspondent Tags: Medical research Antibiotics Society Science UK news US news World news Colorado Source Type: news

Body composition analysis shows utility on CT
With help of artificial intelligence, CT-based body composition analysis show...Read more on AuntMinnie.comRelated Reading: Imaging findings on chest CT help predict lung cancer SBRT outcome MRI scans can reveal body composition changes over time Body composition foretells ovarian cancer treatment complications Automated pipeline enables body composition analysis on chest CT Body composition analysis predicts mortality in spinal metastases (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 3, 2022 Category: Radiology Source Type: news

COVID in the Donor Organ: What's the Risk?
(MedPage Today) -- Three U.S. lung transplant recipients contracted COVID-19 from their new organs, including one patient who died and two patients who transmitted the virus to others, researchers found. From March 2020 to March 2021, nine SARS... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - May 3, 2022 Category: Infectious Diseases Source Type: news

External blood oxygenation saved hundreds of Covid-19 sufferers – study
Adding oxygen to blood using ECMO process found to cause big increase in survival rate in severe casesScores of severely ill Covid-19 sufferers survived because they were given the NHS ’s highest form of intensive care in which an artificial lung breathes for them, astudy has found.Patients in the UK who underwent extracorporeal membrane oxygenation (ECMO) were more likely to survive than those who did not have the treatment, according to the research.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 29, 2022 Category: Science Authors: Denis Campbell Health policy editor Tags: NHS Coronavirus Science Health Infectious diseases Society Medical research UK news Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good sales growth in the first quarter of 2022
Basel, 25 April 2022Group sales increase 11%1 at constant exchange rates (CER) and 10% in Swiss francsPharmaceuticals Divisionsales up 6%; continued strong sales of new medicines for severe diseases. Impact of biosimilars decreases as expected.Diagnostics Divisionsales grow 24% due to good momentum in base business and continued high demand for COVID-19 tests. After a strong first quarter, significant decline in COVID-19-related testing expected.Highlights in the first quarter:FDA approval of Vabysmo (severe eye diseases); CHMP recommends EU approval of Polivy combination (aggressive form of blood cancer), Tecentriq (early...
Source: Roche Media News - April 25, 2022 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good sales growth in the first quarter of 2022
Group sales increase 11%1 at constant exchange rates (CER) and 10% in Swiss francsPharmaceuticals Divisionsales up 6%; continued strong sales of new medicines for severe diseases. Impact of biosimilars decreases as expected.Diagnostics Divisionsales grow 24% due to good momentum in base business and continued high demand for COVID-19 tests. After a strong first quarter, significant decline in COVID-19-related testing expected.Highlights in the first quarter:FDA approval of Vabysmo (severe eye diseases); CHMP recommends EU approval of Polivy combination (aggressive form of blood cancer), Tecentriq (early-stage non-small cel...
Source: Roche Investor Update - April 25, 2022 Category: Pharmaceuticals Source Type: news

Dual-tracer PET/CT shows promise in cancer imaging
Two PET/CT radiotracers -- F-18 FDG and gallium-68 FAPI-46 -- work better togethe...Read more on AuntMinnie.comRelated Reading: PET imaging lays foundation for new cancer therapies PET tracer shows promise for diagnosing breast cancer New PET radiotracer more effective at detecting cancer Animal study suggests Ga-68 PET FAPI can detect lung fibrosis Dual-tracer PET/CT helps pick patients for liver transplant (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 20, 2022 Category: Radiology Source Type: news

Cough-Specific QOL Linked to Poor Outcomes in ILD Patients Cough-Specific QOL Linked to Poor Outcomes in ILD Patients
Poor cough-specific quality-of-life scores were associated with hospitalization, death, and lung transplantation in patients with interstitial lung disease (ILD).Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 19, 2022 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news

Did China's Transplant Docs Violate Dead Donor Rule?
(MedPage Today) -- The "dead donor rule" for heart and lung transplants was itself seemingly dead in China, as papers appearing in the nation's medical journals indicate that physicians involved in the system had ignored internationally agreed... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - April 6, 2022 Category: Surgery Source Type: news

Data from New VOYAGER PAD Analyses at ACC.22 Reinforce Benefit of XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Peripheral Artery Disease (PAD) and Various Co-Morbid Conditions
RARITAN, N.J., April 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from new analyses from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefit of the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) in reducing severe vascular events in patients with PAD after lower-extremity revascularization (LER), a procedure that restores blood flow to the legs. Data from the two analyses demonstrate the role that the XARELTO® vascular dose plays in PAD patients with and without chronic kidney disease (CKD) and in PAD patients with and ...
Source: Johnson and Johnson - April 1, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Novel AI approach stands out detecting COVID-19 on chest x-rays
COVID-19 can be detected and classified on chest x-rays by an artificial intelligenc...Read more on AuntMinnie.comRelated Reading: AI algorithms identify TB on lateral chest x-rays AI detects pneumothorax after lung needle biopsies Digital x-ray shows value during COVID-19 pandemic AI boosts rads' COVID-19 x-ray diagnosis performance Open-source AI COVID-Net targets COVID-19 on chest x-rays (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 31, 2022 Category: Radiology Source Type: news

Qure.ai nets $40M in new funding round
Artificial intelligence software developer Qure.ai has raised $40 millio...Read more on AuntMinnie.comRelated Reading: Qure.ai gets nod for AI tube placement software AI can stratify risk of COVID-19 based on chest x-rays Qure.ai secures FDA clearance for qER-Quant Fujifilm's x-ray system connected with Qure.ai algorithm AstraZeneca, Qure.ai partner for lung cancer diagnosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 29, 2022 Category: Radiology Source Type: news

Lung Transplant in Patient With Terminal Lung Cancer Lung Transplant in Patient With Terminal Lung Cancer
Surgeons in Chicago performed a double lung transplant in a patient with terminal stage 4 lung cancer. Six months later the patient is cancer free.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - March 25, 2022 Category: Transplant Surgery Tags: Hematology-Oncology News Source Type: news

Double-lung transplant saves Chicago man with terminal lung cancer
In what may be a first in the United States, surgeons at Northwestern Medicine in Chicago performed a successful double-lung transplant on a patient with terminal lung cancer, the hospital announced Thursday. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 24, 2022 Category: Consumer Health News Source Type: news